×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Even With A 25% Surge, Cautious Investors Are Not Rewarding Viva Biotech Holdings' (HKG:1873) Performance Completely
Simply Wall Street
Viva Biotech Holdings ( HKG:1873 ) shareholders would be excited to see that the share price has had a great month...
2 weeks ago
Latest biotech news: fundraises, deals, clinical trials | Nov 24, 2023
Labiotech.eu
What's been going on in the world of biotech of late? Find out with Labiotech's weekly roundup of the latest biotech news.
5 months ago
Temasek-backed firms buy stake in VIVA Biotech unit ahead of listing
Reuters
June 12 (Reuters) - Entities backed by Singapore's Temasek and Chinese investment firm HighLight Capital agreed to a deal worth 1.06 billion...
11 months ago
Viva Biotech Advances CRO, CDMO Products, Secures $210M Investment
Contract Pharma
Viva Biotech Holdings Group reported that Viva Shanghai, the primary entity for Viva Biotech's CRO business, successfully raised nearly $150...
11 months ago
Positive Sentiment Still Eludes Viva Biotech Holdings (HKG:1873) Following 27% Share Price Slump
Simply Wall Street
Viva Biotech Holdings' P/S ratio would be typical for a company that's expected to deliver very poor growth or even falling revenue, and...
3 months ago
Viva Biotech Holdings' (HKG:1873) market cap up HK$193m last week, benefiting both individual investors who own 45% as well as insiders
Simply Wall Street
Hedge funds don't have many shares in Viva Biotech Holdings. Jiong Wu is currently the largest shareholder, with 10% of shares outstanding. For...
1 month ago
Temasek-backed firms buy stake in Viva Biotech unit ahead of listing
The Business Times
Cryptocurrencies fell Monday (Jun 12), though staying above their weekend lows, as last week's regulatory crackdown by the US Securities and...
11 months ago
Novartis Acquires DTx Pharma, for Approx. USD1 Billion
FinSMEs
Novartis acquired DTx Pharma, a San Diego, CA-based biotechnology company, for approx. $1 Billion. Novartis will make an upfront payment of...
9 months ago
Firms backed by Temasek, HighLight Capital buy stake in Viva Biotech unit ahead of listing
The Straits Times
VIVA Biotech said it will use the net proceeds to redeem convertible bonds. Read more at straitstimes.com.
11 months ago
How to make big money from early stage biotechs
The Australian
Andrew Wilks – the scientist who discovered a molecule that pharmaceutical titan GSK bought for $1.9bn last year – is launching his own...
8 months ago